A Six-Week, Double-Blind, Multicenter, Placebo Controlled Study Evaluating The Efficacy And Safety Of Flexible Doses Of Oral Ziprasidone As Add-On, Adjunctive Therapy With Lithium, Valproate Or Lamotrigine In Bipolar I Depression.

Trial Profile

A Six-Week, Double-Blind, Multicenter, Placebo Controlled Study Evaluating The Efficacy And Safety Of Flexible Doses Of Oral Ziprasidone As Add-On, Adjunctive Therapy With Lithium, Valproate Or Lamotrigine In Bipolar I Depression.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Mar 2010

At a glance

  • Drugs Lamotrigine; Lithium; Valproic acid; Ziprasidone
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 30 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 30 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Jan 2009 Planned number of patients changed from 282 to 298 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top